Former co-founder, Symmetry Health Data Systems, Inc. a healthcare analytics firm, sold to United Health Group in 2003. Co-Founder, PharMetrics, a Boston-based health analytics company specializing in pharmacoeconomic reporting to the pharmacy industry. PharMetrics was sold to IMS Health in 2005.

Mr. Karratt has designed and developed medical devices for a variety of companies and indications. He has held positions in the capacity of technical contributor to principal engineer, in addition to being a consultant for early stage startups looking to expand their initial intellectual property. Mr. Karratt has contributed to several companies including Medtronic, Xtent and Bioabsorbable Therapeutics, with a focus on Research and Development.

Dr. Ofir Goldberger is a post doctoral fellow at Stanford School of Medicine, where he is doing research in immunology. Dr. Goldberger is a graduate of Stanford Graduate School of Business's Program in Innovation and Entrepreneurship (PRIE), he received his Ph.D. and M.Sc. from the Weizmann Institute of Science on cancer immunology, and his B.Sc. in life sciences from Tel Aviv University. He has a total of 13 years research experience in immunolo

Ellen Kramer has 20 years experience as a licensed Architect and Designer for a number of innovative and well-known Silicon Valley firms. Ms. Kramer’s clients include Apple, Lunar Design, Palantir and Siebel Foundation (First Virtual Group).Ms. Kramer has been at the forefront of food allergy management since 1995, having initiated and designed the first food allergy management protocols in the Menlo Park City School District.

Mr. Rosenbaum is a Registered Patent Attorney with over twenty-seven years of experience in life science related technologies, including medical devices, pharmaceuticals and biotechnology. David is the founding shareholder of RosenbaumIP, an intellectual property law firm with a practice emphasis on intellectual property portfolio management.